文献速递肿瘤 PET/CT放射性药物与辐射防护

99mTc-PSMA显像中的游离TcO4-:一例病例报告及现代影像时代旧陷阱的回顾

Free TcO 4- in 99m Tc-PSMA Scan : A Case Report and Review of an Old Pitfall in the New Era of Modern Imaging.
PubMed 文献 · Clin Nucl Med · 2024-04-30

本科室在同一天对2例前列腺癌患者进行99mTc-HYNIC-PSMA初始分期显像,全身扫描见胃黏膜和甲状腺摄取放射性示踪剂,提示注射瓶中游离TcO4-水平高。在确认放射性药物纯度97%(正常范围95%-100%)后重复扫描;1例患者初诊时有肝转移,重复扫描后仍无PSMA摄取。作者回顾了这一在许多放射性示踪剂中已有报道、但在PSMA示踪剂中尚未报道的陷阱。

要点

  • 99mTc-PSMA全身扫描出现胃黏膜和甲状腺摄取时,应警惕注射瓶中游离TcO4-水平高。
  • 放射性药物纯度97%(正常范围95%-100%)在可接受范围内,但仍可出现游离TcO4-相关摄取。
  • 1例初诊有肝转移的患者重复扫描后肝转移仍无PSMA摄取。

核心结论

  • 99mTc-PSMA显像中胃黏膜和甲状腺摄取提示注射瓶中游离TcO4-水平高,该陷阱已在许多放射性示踪剂中报道,但在PSMA示踪剂中尚未报道。

研究设计与样本

  • 本科室开展的99mTc-HYNIC-PSMA研究,同一天检查2例转诊进行初始分期的前列腺癌患者。

主要发现

  • 全身扫描显示胃黏膜和甲状腺摄取放射性示踪剂,提示注射瓶中游离TcO4-水平高。
  • 确认放射性药物纯度97%(正常范围95%-100%)后重复扫描。
  • 1例患者初诊时有肝转移,重复扫描后肝转移仍无PSMA摄取。

关键数值与推荐

  • 放射性药物纯度97%,正常范围95%-100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In a recent 99m Tc-HYNIC-PSMA study conducted at our department, we examined 2 patients with prostate cancer referred for initial staging on the same day. The whole-body scans revealed radiotracer uptake in the gastric mucosa and thyroid glands, alluding to high levels of free TcO 4- in the injected vial. The scans were repeated after confirming acceptable radiopharmaceutical purity of 97% (normal range, 95%-100%). Interestingly, 1 patient had liver metastases at presentation, which remained non-PSMA-avid after repeating the scan. We have reviewed this pitfall, which has been reported with many radiotracers, yet not reported with PSMA tracers.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Sahafi P, Aryana K, Moghadam SZ, et al. Free TcO 4- in 99m Tc-PSMA Scan : A Case Report and Review of an Old Pitfall in the New Era of Modern Imaging. Clin Nucl Med. 2024. PMID: 38687008. doi:10.1097/RLU.0000000000005240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。